Response by Horiuchi et al to Letter Regarding Article, “Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction”
- 23 February 2021
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Cardiology
- Vol. 143 (8), e252-e253
- https://doi.org/10.1161/circulationaha.120.051634
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Role of Admission Troponin‐T and Serial Troponin‐T Testing in Predicting Outcomes in Severe Sepsis and Septic ShockJournal of the American Heart Association, 2017
- Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic reviewJournal of the Intensive Care Society, 2014
- Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure SectionEuropean Heart Journal, 2012
- Troponin Elevation in Heart Failure: Prevalence, Mechanisms, and Clinical ImplicationsJournal of Invasive Cardiology, 2010
- Procalcitonin in acute myocardial infarctionAcute Cardiac Care, 2008